Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The report details the trend, potential and market size of Drug, Anti-infective market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drug, Anti-infectivemarket, defines the market attractiveness level of Drug, Anti-infective market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drug, Anti-infective industry, describes the types of Drug, Anti-infective market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drug, Anti-infective market and the development prospects and opportunities of Drug, Anti-infective industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drug, Anti-infective market in Chapter 13.
By Player:
Optimer Pharmaceuticals
Sanofi-Aventis
Novabay Pharmaceuticals
Pfizer
Johnson
Basilea Pharmaceutica AG
Merck
Novartis AG
Daiichi Sankyo
MerLion Pharma
Theravance
Nanosphere
GlaxoSmithKline
NanoViricides
Obetech
Roche Pharma AG
Wyeth
Abbott
Gilead Sciences
Bristol-Myers Squibb
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Drugs Store
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drug, Anti-infective Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drug, Anti-infective Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drug, Anti-infective Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drug, Anti-infective Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drug, Anti-infective Market Analysis and Outlook to 2022
-
7.1 Global Drug, Anti-infective Consumption (2017-2022)
-
7.2 United States Drug, Anti-infective Consumption (2017-2022)
-
7.3 Europe Drug, Anti-infective Consumption (2017-2022)
-
7.4 China Drug, Anti-infective Consumption (2017-2022)
-
7.5 Japan Drug, Anti-infective Consumption (2017-2022)
-
7.6 India Drug, Anti-infective Consumption (2017-2022)
-
7.7 South Korea Drug, Anti-infective Consumption (2017-2022)
8 Region and Country-wise Drug, Anti-infective Market Analysis and Outlook to 2028
-
8.1 Global Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.2 United States Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.3 Europe Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.4 China Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.5 Japan Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.6 India Drug, Anti-infective Consumption Forecast (2022-2028)
-
8.7 South Korea Drug, Anti-infective Consumption Forecast (2022-2028)
9 Global Drug, Anti-infective Market Outlook by Types and Applications to 2022
-
9.1 Global Drug, Anti-infective Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Drug, Anti-infective Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Drug, Anti-infective Market Outlook by Types and Applications to 2028
-
10.1 Global Drug, Anti-infective Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drug, Anti-infective Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Drug, Anti-infective Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drug, Anti-infective Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drug, Anti-infective Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drug, Anti-infective Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drug, Anti-infective Market Competitive Analysis
-
14.1 Optimer Pharmaceuticals
-
14.1.1 Optimer Pharmaceuticals Company Details
-
14.1.2 Optimer Pharmaceuticals Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Optimer Pharmaceuticals Drug, Anti-infective Product and Service
-
14.2 Sanofi-Aventis
-
14.2.1 Sanofi-Aventis Company Details
-
14.2.2 Sanofi-Aventis Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi-Aventis Drug, Anti-infective Product and Service
-
14.3 Novabay Pharmaceuticals
-
14.3.1 Novabay Pharmaceuticals Company Details
-
14.3.2 Novabay Pharmaceuticals Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novabay Pharmaceuticals Drug, Anti-infective Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Drug, Anti-infective Product and Service
-
14.5 Johnson
-
14.5.1 Johnson Company Details
-
14.5.2 Johnson Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson Drug, Anti-infective Product and Service
-
14.6 Basilea Pharmaceutica AG
-
14.6.1 Basilea Pharmaceutica AG Company Details
-
14.6.2 Basilea Pharmaceutica AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Basilea Pharmaceutica AG Drug, Anti-infective Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Drug, Anti-infective Product and Service
-
14.8 Novartis AG
-
14.8.1 Novartis AG Company Details
-
14.8.2 Novartis AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis AG Drug, Anti-infective Product and Service
-
14.9 Daiichi Sankyo
-
14.9.1 Daiichi Sankyo Company Details
-
14.9.2 Daiichi Sankyo Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Daiichi Sankyo Drug, Anti-infective Product and Service
-
14.10 MerLion Pharma
-
14.10.1 MerLion Pharma Company Details
-
14.10.2 MerLion Pharma Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 MerLion Pharma Drug, Anti-infective Product and Service
-
14.11 Theravance
-
14.11.1 Theravance Company Details
-
14.11.2 Theravance Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Theravance Drug, Anti-infective Product and Service
-
14.12 Nanosphere
-
14.12.1 Nanosphere Company Details
-
14.12.2 Nanosphere Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Nanosphere Drug, Anti-infective Product and Service
-
14.13 GlaxoSmithKline
-
14.13.1 GlaxoSmithKline Company Details
-
14.13.2 GlaxoSmithKline Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 GlaxoSmithKline Drug, Anti-infective Product and Service
-
14.14 NanoViricides
-
14.14.1 NanoViricides Company Details
-
14.14.2 NanoViricides Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 NanoViricides Drug, Anti-infective Product and Service
-
14.15 Obetech
-
14.15.1 Obetech Company Details
-
14.15.2 Obetech Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Obetech Drug, Anti-infective Product and Service
-
14.16 Roche Pharma AG
-
14.16.1 Roche Pharma AG Company Details
-
14.16.2 Roche Pharma AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Roche Pharma AG Drug, Anti-infective Product and Service
-
14.17 Wyeth
-
14.17.1 Wyeth Company Details
-
14.17.2 Wyeth Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Wyeth Drug, Anti-infective Product and Service
-
14.18 Abbott
-
14.18.1 Abbott Company Details
-
14.18.2 Abbott Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Abbott Drug, Anti-infective Product and Service
-
14.19 Gilead Sciences
-
14.19.1 Gilead Sciences Company Details
-
14.19.2 Gilead Sciences Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Gilead Sciences Drug, Anti-infective Product and Service
-
14.20 Bristol-Myers Squibb
-
14.20.1 Bristol-Myers Squibb Company Details
-
14.20.2 Bristol-Myers Squibb Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Bristol-Myers Squibb Drug, Anti-infective Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drug, Anti-infective
-
Figure Drug, Anti-infective Picture
-
Table Global Drug, Anti-infective Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug, Anti-infective Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drug, Anti-infective Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drug, Anti-infective Consumption by Country (2017-2022)
-
Figure United States Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Table Europe Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Figure China Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Figure Japan Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Figure India Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drug, Anti-infective Consumption and Growth Rate (2017-2022)
-
Figure Global Drug, Anti-infective Consumption Forecast by Country (2022-2028)
-
Figure United States Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drug, Anti-infective Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drug, Anti-infective Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drug, Anti-infective Export by Region (Top 5 Countries) (2017-2028)
-
Table Optimer Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Optimer Pharmaceuticals Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Optimer Pharmaceuticals Drug, Anti-infective Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Drug, Anti-infective Product and Service
-
Table Novabay Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Novabay Pharmaceuticals Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novabay Pharmaceuticals Drug, Anti-infective Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drug, Anti-infective Product and Service
-
Table Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson Drug, Anti-infective Product and Service
-
Table Basilea Pharmaceutica AG (Foundation Year, Company Profile and etc.)
-
Table Basilea Pharmaceutica AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Basilea Pharmaceutica AG Drug, Anti-infective Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drug, Anti-infective Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Drug, Anti-infective Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Drug, Anti-infective Product and Service
-
Table MerLion Pharma (Foundation Year, Company Profile and etc.)
-
Table MerLion Pharma Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table MerLion Pharma Drug, Anti-infective Product and Service
-
Table Theravance (Foundation Year, Company Profile and etc.)
-
Table Theravance Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Drug, Anti-infective Product and Service
-
Table Nanosphere (Foundation Year, Company Profile and etc.)
-
Table Nanosphere Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanosphere Drug, Anti-infective Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Drug, Anti-infective Product and Service
-
Table NanoViricides (Foundation Year, Company Profile and etc.)
-
Table NanoViricides Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table NanoViricides Drug, Anti-infective Product and Service
-
Table Obetech (Foundation Year, Company Profile and etc.)
-
Table Obetech Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Obetech Drug, Anti-infective Product and Service
-
Table Roche Pharma AG (Foundation Year, Company Profile and etc.)
-
Table Roche Pharma AG Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Pharma AG Drug, Anti-infective Product and Service
-
Table Wyeth (Foundation Year, Company Profile and etc.)
-
Table Wyeth Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wyeth Drug, Anti-infective Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Drug, Anti-infective Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Drug, Anti-infective Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Drug, Anti-infective Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Drug, Anti-infective Product and Service
-
